Mind Medicine (MindMed) Inc. announced that it has entered into a share purchase agreements for a concurrent private placement of 12,500,000 common shares at a price of $6 per common share for the gross proceeds of $75,000,000 on March 7, 2024. The transaction is expected to close on or about March 11, 2024, subject to the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.07 USD | +6.83% | -5.62% | +147.81% |
May. 13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
May. 08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.81% | 610M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Mind Medicine Inc. announced that it expects to receive $75 million in funding from Deep Track Capital, LP, Commodore Capital